NCT07609823

A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-07-30Est. Completion: 2028-03-30

Enrollment target: 75 participants

Contact

B-AllAcute Lymphoblastic Leukemia

Background: B-cell acute lymphoblastic leukemia (B-ALL) is a type of blood cancer. Some people with B-ALL have a gene m…

Bethesda, United StatesEst. completion Jun 30, 2030

Hematologic Cancer

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood …

Tempe, United StatesEst. completion Mar 2031

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.